3SBio Inc. disclosed that it repurchased 1.30 million ordinary shares on 28 September 2026 via on-market transactions on the Hong Kong Stock Exchange, paying a total of HK$20.41 million. The shares were bought at prices ranging between HK$15.60 and HK$15.80, implying a volume-weighted average cost of roughly HK$15.70 per share.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased to 2.52 billion shares from 2.52 billion, representing a 0.05% reduction. Concurrently, treasury shares rose to 18.48 million. The total number of issued shares, including treasury stock, remained unchanged at 2.54 billion.

The buyback was executed under the general mandate approved on 25 June 2026, which authorises the repurchase of up to 253.71 million shares. Cumulative repurchases under this mandate now stand at 17.46 million shares, equivalent to 0.69% of the company’s issued share count at the mandate date.

3SBio is barred from issuing new shares or disposing of treasury shares until 28 October 2026, reflecting the 30-day moratorium mandated by Hong Kong listing rules after share repurchases.